310
CytomX Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
237
FY23:
183
FY24:
107
FY25:
144
(positive)
Change from FY21 to FY25
millions USD
FY21:
29.1
FY22:
23.8
FY23:
18.9
FY24:
13.2
FY25:
7.65
Total assets
Change from FY21 to FY25
millions USD
FY21:
339
FY22:
261
FY23:
202
FY24:
121
FY25:
152
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
77.9
FY22:
153
FY23:
156
FY24:
85.8
FY25:
46.6
(negative)
Change from FY21 to FY25
millions USD
FY21:
262
FY22:
194
FY23:
93.3
FY24:
35.2
FY25:
5.94
(positive)
Change from FY21 to FY25
millions USD
FY21:
−0.46
FY22:
−85.8
FY23:
−47.4
FY24:
−0.46
FY25:
99.0
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
339
FY22:
261
FY23:
202
FY24:
121
FY25:
152
All amounts in millions USD